FDA.reportPublic FDA data

HLA class I antibody identification panel IVD, kit, complement-dependent cytotoxicity (CDC)

Definition
A collection of reagents and other associated materials intended to be used for the identification in a clinical specimen of one or multiple antibodies to HLA class I antigens, using lymphocyte antigens together with a complement-dependent cytotoxicity (CDC) method.
GUDID devices
2
Last updated
2019-04-02 21:21:59

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
07611969952939Lymphoscreen ABC-60Bio-Rad Medical Diagnostics GmbH8233002015-07-01
07611969965700Lymphoscreen ABC-60Bio-Rad Medical Diagnostics GmbH8233002018-03-08